Blog

Crushing Systems and USP 800 Compliance

Angie Pace

https://www.pharmacytimes.com/view/crushing-systems-and-usp-800-compliance

Crushing Systems and USP 800 Compliance

Angie Pace

https://www.pharmacytimes.com/view/crushing-systems-and-usp-800-compliance

USP<797> Pill Crushing, RxCrush

Angie Pace

Millions of doses of medications are compounded each year in the United States. Its estimated that as many as 190,000,000 are prepared each year. Drug compounding is the process of...

USP<797> Pill Crushing, RxCrush

Angie Pace

Millions of doses of medications are compounded each year in the United States. Its estimated that as many as 190,000,000 are prepared each year. Drug compounding is the process of...

GEDSA Supports FDA Safety Communication on ENFi...

Angie Pace

GEDSA Supports FDA Safety Communication on ENFit® Low Dose Tip Syringe Proper Labelling and Training Materials Requested from ManufacturersNovember 02, 2021 11:44 AM Eastern Daylight Time POWELL, Ohio--(BUSINESS WIRE)--On October...

GEDSA Supports FDA Safety Communication on ENFi...

Angie Pace

GEDSA Supports FDA Safety Communication on ENFit® Low Dose Tip Syringe Proper Labelling and Training Materials Requested from ManufacturersNovember 02, 2021 11:44 AM Eastern Daylight Time POWELL, Ohio--(BUSINESS WIRE)--On October...

USP<800>, Pill Crushing, and RxCrush-Guidance a...

Angie Pace

The U.S. Pharmacopeial Convention (USP) recently updated their General Chapter USP<800>; in December of 2019. USP General Chapter 800 sets the standards of how to handle hazardous drugs in clinical...

USP<800>, Pill Crushing, and RxCrush-Guidance a...

Angie Pace

The U.S. Pharmacopeial Convention (USP) recently updated their General Chapter USP<800>; in December of 2019. USP General Chapter 800 sets the standards of how to handle hazardous drugs in clinical...

ENFit LDT Syringes

Angie Pace

The FDA continues to recommend the use of enteral devices and syringes that reduce the risk of misconnections, such as ENFit LDT syringes.https://www.businesswire.com/news/home/20211102005986/en/GEDSA-Supports-FDA-Safety-Communication-on-ENFit%C2%AE-Low-Dose-Tip-Syringe

ENFit LDT Syringes

Angie Pace

The FDA continues to recommend the use of enteral devices and syringes that reduce the risk of misconnections, such as ENFit LDT syringes.https://www.businesswire.com/news/home/20211102005986/en/GEDSA-Supports-FDA-Safety-Communication-on-ENFit%C2%AE-Low-Dose-Tip-Syringe